Bamforth Mark R

Director at CDMO; Sr.VP, Corp. Operations & Phar at GENZYME CORP

Sold, on record
$4.4M
Dollars the filings state
Form 4 sales
3
Latest Mar 17, 2021
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale GENZYME CORPUnusual
    Aug 6, 2008 2008

    Sold 6,445 shares at $79.00 ($509k)

    Bamforth Mark R, Sr.VP, Corp. Operations & Phar

    Sold 97.6% of holdings ($522k position)158 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale GENZYME CORPUnusual
    Aug 14, 2008 +8 days

    Sold 19,232 shares at $81.71 ($1.6M)

    Bamforth Mark R, Sr.VP, Corp. Operations & Phar

    Sold 99.2% of holdings ($1.6M position)158 shares leftFiling

  3. 3 Form 4 sale CDMOUnusual
    Mar 17, 2021 +4598 days

    Sold 126,000 shares at $18.18 ($2.3M)

    Bamforth Mark R, Director

    Sold 100% of holdings ($2.3M position)0 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Bamforth Mark R
Source
Mar 17, 2021Mar 19, 2021CDMODirectorForm 4 sale126,000$2.3M100.0%UnusualSEC
Aug 14, 2008Aug 15, 2008GENZYME CORPSr.VP, Corp. Operations & PharForm 4 sale19,232$1.6M99.2%UnusualSEC
Aug 6, 2008Aug 7, 2008GENZYME CORPSr.VP, Corp. Operations & PharForm 4 sale6,445$509k97.6%UnusualSEC